1. Torbicki A,Pettier A,Konstantinides S,et al.Guidelines on the diagnosis and management of acute pulmonary embolism:the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology(ESC).Eur Heart J,2008,29:2276-2315.
[2]
3. Geerts WH,Bergqvist D,Pineo GF,et al.Prevention of venous thromboembolism:American College of Chest Physicians Evidenced-Based Clinical Practice Guidelines.Chest,2008,133,381S-453S.
[3]
5. Carvalho Bricola SA,Paiva EF,Lichtenstein A.Fatal pulmonary embolism in hospitalized patients:a large autopsy-based matched case-control study.Clinics(Sao Paulo),2013,68:679-685.
[4]
6. Goran KP.Thrombolysis during cardiopulmonary resuscitation should be addressed in guidelines for pulmonary embolism.Eur Heart J,2008,29:3066-3067.
[5]
8. Konstantinides SV,Torbicki A,Agnelli G,et al.2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism.Eur Heart J,2014,35:3033-3069.
2. Andrzej C.Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of low molecular weight heparin-Gynecologicar ward retrospective analysis.Eur J Obstet Gynecol Reprod Biol,2002,100:223-226.
[8]
4. Laporte S,Mismetti P,Décousus H,et al.Clinical predictors for fatal pulmonary embolism in 15520 patients with venous thromboembolism:findings from the Registro Informatizado de la Enfermed and Trombo Embolica venosa (RIETE)Registry.Circulation,2008,117:1711-1716.
[9]
7. Logan JK,Pantle H,Huiras P,et al.Evidence-based diagnosis and thrombolytic treatment of cardiac arrest or periarrest due to suspected pulmonary embolism.Am J Emerg Med,2014,32:789-796.
10. Wang C,Zhai Z,Yang Y,et al.Efficacy and safety of low dose recombinant tissue-type plasminogen activator for the treatment of acute pulmonary thromboembolism:a randomized,multicenter,controlled trial.Chest,2010,137:254-262.
